These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 28692636)
1. The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax. Liu X; Dong J; Cai W; Pan Y; Li R; Li B Int J Gynecol Cancer; 2017 Oct; 27(8):1596-1601. PubMed ID: 28692636 [TBL] [Abstract][Full Text] [Related]
2. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403 [TBL] [Abstract][Full Text] [Related]
3. The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells. Shinagawa A; Yoshida Y; Kurokawa T; Horiuchi Y; Tsuyoshi H; Orisaka M; Sawamura Y; Kleinman HK; Kotsuji F Int J Oncol; 2011 Dec; 39(6):1359-64. PubMed ID: 21935568 [TBL] [Abstract][Full Text] [Related]
4. [Effects of compound Daqiqi decoction combined cisplatin on Bcl-2/Bax expression of nude mice ovarian cancer subcutaneous transplanted tumor]. Yang YB; Wang S; Li S; Chen R Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1575-9. PubMed ID: 26281601 [TBL] [Abstract][Full Text] [Related]
5. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules. Zhang XQ; Ding YW; Chen JJ; Xiao X; Zhang W; Zhou L; Kong QW; Shi MZ; Yang J; Jiang B; Guo C; Han YL J Ethnopharmacol; 2020 Oct; 261():113067. PubMed ID: 32505840 [TBL] [Abstract][Full Text] [Related]
6. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein. Ng WK; Yazan LS; Ismail M Toxicol In Vitro; 2011 Oct; 25(7):1392-8. PubMed ID: 21609759 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway. Zhang C; Wang M; Shi C; Shi F; Pei C Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351 [TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Yasmeen A; Beauchamp MC; Piura E; Segal E; Pollak M; Gotlieb WH Gynecol Oncol; 2011 Jun; 121(3):492-8. PubMed ID: 21388661 [TBL] [Abstract][Full Text] [Related]
9. [Effects of Zengmian Yiliu Recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer]. Qi C; Zhang QH; Li JX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):817-21. PubMed ID: 22978111 [TBL] [Abstract][Full Text] [Related]
10. Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway. Hu X; Ma J; Vikash V; Li J; Wu D; Liu Y; Zhang J; Dong W Dig Dis Sci; 2018 Jan; 63(1):126-134. PubMed ID: 29197940 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma. Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753 [TBL] [Abstract][Full Text] [Related]
13. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Simonin K; Brotin E; Dufort S; Dutoit S; Goux D; N'diaye M; Denoyelle C; Gauduchon P; Poulain L Mol Cancer Ther; 2009 Nov; 8(11):3162-70. PubMed ID: 19887550 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Proliferation and Induction of Apoptosis by Thymoquinone via Modulation of TGF Family, p53, p21 and Bcl-2α in Leukemic Cells. Diab-Assaf M; Semaan J; El-Sabban M; Al Jaouni SK; Azar R; Kamal MA; Harakeh S Anticancer Agents Med Chem; 2018; 18(2):210-215. PubMed ID: 28901264 [TBL] [Abstract][Full Text] [Related]
15. Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression. Villedieu M; Briand M; Duval M; Héron JF; Gauduchon P; Poulain L Gynecol Oncol; 2007 May; 105(2):373-84. PubMed ID: 17276501 [TBL] [Abstract][Full Text] [Related]
16. Metformin and epithelial ovarian cancer therapeutics. Patel S; Kumar L; Singh N Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765 [TBL] [Abstract][Full Text] [Related]
17. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells. Samarghandian S; Azimi-Nezhad M; Farkhondeh T J Cell Physiol; 2019 Jul; 234(7):10421-10431. PubMed ID: 30387147 [TBL] [Abstract][Full Text] [Related]
18. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro. Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells. Dos Santos Ferreira AC; Fernandes RA; Kwee JK; Klumb CE J Cancer Res Clin Oncol; 2012 Feb; 138(2):317-25. PubMed ID: 22131152 [TBL] [Abstract][Full Text] [Related]
20. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D Idris S; Refaat B; Almaimani RA; Ahmed HG; Ahmad J; Alhadrami M; El-Readi MZ; Elzubier ME; Alaufi HAA; Al-Amin B; Alghamdi AA; Bahwerth F; Minshawi F; Kabrah SM; Aslam A Life Sci; 2022 May; 296():120442. PubMed ID: 35245520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]